Research and development effort in developing the optimal formulations for new tablet drugs

[1]  Douglas C. Montgomery,et al.  Modified Desirability Functions for Multiple Response Optimization , 1996 .

[2]  Byung Rae Cho,et al.  ECONOMIC DESIGN AND DEVELOPMENT OF SPECIFICATIONS , 1994 .

[3]  Ajaz S. Hussain,et al.  Feasibility of Developing a Neural Network for Prediction of Human Pharmacokinetic Parameters from Animal Data , 1993, Pharmaceutical Research.

[4]  Leon Shargel,et al.  Applied biopharmaceutics and pharmacokinetics , 1980 .

[5]  P. Houpert,et al.  Effect of U3O8 Specific Surface Area on In Vitro Dissolution, Biokinetics, and Dose Coefficients , 1998 .

[6]  Byung Rae Cho,et al.  Solving Multiresponse Optimization Problems Using Quality Function–Based Robust Design , 2008 .

[7]  K. Tsutani,et al.  Approval of new drugs 1999–2007: comparison of the US, the EU and Japan situations , 2010, Journal of clinical pharmacy and therapeutics.

[8]  N. Anthony Armstrong,et al.  Pharmaceutical Experimental Design and Interpretation , 1996 .

[9]  N. Anderson,et al.  An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. , 1998, Journal of pharmaceutical and biomedical analysis.

[10]  Pedro Hernandez-Abad,et al.  Quality by design case study: an integrated multivariate approach to drug product and process development. , 2009, International journal of pharmaceutics.

[11]  Kozo Takayama,et al.  Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations , 1997 .

[12]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.

[13]  Byung Rae Cho,et al.  Development of realistic quality loss functions for industrial applications , 2006 .

[14]  Paul L. Goethals,et al.  Extending the desirability function to account for variability measures in univariate and multivariate response experiments , 2012, Comput. Ind. Eng..

[15]  G. Box,et al.  Some New Three Level Designs for the Study of Quantitative Variables , 1960 .

[16]  M. Natália D. S. Cordeiro,et al.  Desirability‐based multiobjective optimization for global QSAR studies: Application to the design of novel NSAIDs with improved analgesic, antiinflammatory, and ulcerogenic profiles , 2008, J. Comput. Chem..

[17]  K. C. Yeh,et al.  A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[18]  T. Higuchi.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[19]  D. Patel,et al.  Floating granules of ranitidine hydrochloride-gelucire 43/01: Formulation optimization using factorial design , 2007, AAPS PharmSciTech.

[20]  G. Geoffrey Vining,et al.  A Compromise Approach to Multiresponse Optimization , 1998 .

[21]  L. Endrenyi,et al.  Variation of Cmax and Cmax/AUC in investigations of bioequivalence. , 1993, International journal of clinical pharmacology, therapy, and toxicology.

[22]  Mark Gibson,et al.  Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commercial Dosage Form , 2001 .

[23]  Y. Tsai,et al.  Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology. , 2004, Biological & pharmaceutical bulletin.

[24]  G. Derringer,et al.  Simultaneous Optimization of Several Response Variables , 1980 .

[25]  M. Patel,et al.  Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation , 2004, AAPS PharmSciTech.

[26]  M Gibaldi,et al.  Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. , 1967, Journal of pharmaceutical sciences.

[27]  C George,et al.  A Balancing Act: Optimizing a Product's Properties , 1994 .

[28]  R. Holm,et al.  Optimization of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Using a D-Optimal Design and the Desirability Function , 2006, Drug development and industrial pharmacy.

[29]  P. Dallas,et al.  Evaluation and simultaneous optimization of some pellets characteristics using a 3(3) factorial design and the desirability function. , 2002, International journal of pharmaceutics.

[30]  Young-Hyun Ko,et al.  A New Loss Function-Based Method for Multiresponse Optimization , 2005 .

[31]  S. Fanali,et al.  An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate. , 2002, Journal of pharmaceutical and biomedical analysis.

[32]  L. Endrenyi,et al.  Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence. , 1991, International journal of clinical pharmacology, therapy, and toxicology.

[33]  M. Khan,et al.  Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. , 2007, International journal of pharmaceutics.

[34]  J. Varshosaz,et al.  Applying the Taguchi Design for Optimized Formulation of Sustained Release Gliclazide Chitosan Beads: An In Vitro/In Vivo Study , 2009, AAPS PharmSciTech.

[35]  Byung Rae Cho,et al.  Identification and Extensions of Quasiconvex Quality Loss Functions , 1997 .

[36]  Richard Hwang,et al.  Application of design of experiments to pharmaceutical formulation development , 2011 .

[37]  Byung Rae Cho,et al.  Another view of dual response surface modeling and optimization in robust parameter design , 2009 .

[38]  Indra K. Reddy,et al.  Atenolol gastrointestinal therapeutic system: optimization of formulation variables using response surface methodology , 1997 .

[39]  Kozo Takayama,et al.  Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations , 2004, Pharmaceutical Research.

[40]  Limits of 80%-125% for AUC and 70%-143% for Cmax. What is the impact on bioequivalence studies? , 2001, International journal of clinical pharmacology and therapeutics.

[41]  J. Carstensen,et al.  Physical model for release of drug from gelforming sustained release preparations , 1979 .

[42]  I Horikoshi,et al.  Optimization of the formulation design of chitosan microspheres containing cisplatin. , 1996, Journal of pharmaceutical sciences.

[43]  C. Caramella,et al.  Water uptake and force development in an optimized prolonged release formulation , 1991 .

[44]  K. A. Khan.  The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.

[45]  John W. Gorman,et al.  Simplex Lattice Designs for Multicomponent Systems , 1962 .

[46]  T. Baykara,et al.  Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. , 2000, International journal of pharmaceutics.

[47]  F. Vrečer,et al.  Application of experimental design methodology in development and optimization of drug release method. , 2005, International journal of pharmaceutics.

[48]  T Nagai,et al.  Formula optimization of theophylline controlled-release tablet based on artificial neural networks. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[49]  J. Neter,et al.  Applied Linear Regression Models , 1983 .

[50]  Sanford Bolton.  Pharmaceutical statistics: Practical and clinical applications , 1984 .

[51]  Supriya Gupta,et al.  Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques , 2003, AAPS PharmSci.

[52]  L. Lesko,et al.  Measures of Exposure versus Measures of Rate and Extent of Absorption , 2001, Clinical pharmacokinetics.

[53]  Shein-Chung Chow,et al.  Design and Analysis of Bioavailability and Bioequivalence Studies , 1994 .

[54]  Michael Levin.  Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .

[55]  Ful-Chiang Wu,et al.  Optimization of Correlated Multiple Quality Characteristics Using Desirability Function , 2004 .

[56]  Kwang-Jae Kim,et al.  Simultaneous optimization of mechanical properties of steel by maximizing exponential desirability functions , 2000 .

[57]  Elsayed A. Elsayed,et al.  Optimal levels of process parameters for products with multiple characteristics , 1993 .

[58]  D. Brockmeier.  In vitro/in vivo correlation of dissolution using moments of dissolution and transit times , 1986 .

[59]  J. Polli,et al.  Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. , 1997, Journal of pharmaceutical sciences.

[60]  C. Rhodes,et al.  Optimization of Tablet Formulations Containing Talc , 1991 .

[61]  R.-C. Hwang,et al.  A Systematic Evaluation of the Compression and Tablet Characteristics of Various Types of Lactose and Dibasic Calcium Phosphate , 2001 .

[62]  Kozo Takayama,et al.  Formulation Optimization of Paclitaxel Carried by PEGylated Emulsions Based on Artificial Neural Network , 2004, Pharmaceutical Research.

[63]  M. Bashiri,et al.  Decision making for interactive optimization of correlated desirability functions , 2009, 2009 IEEE International Conference on Industrial Engineering and Engineering Management.

[64]  T. Beckert,et al.  A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. , 2001, International journal of pharmaceutics.

[65]  A. Khuri,et al.  Simultaneous Optimization of Multiple Responses Represented by Polynomial Regression Functions , 1981 .

[66]  Yi Tsong,et al.  In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2 , 1998, Pharmaceutical Research.

[67]  Jaber Emami,et al.  In vitro - in vivo correlation: from theory to applications. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[68]  S. Chow,et al.  Statistical comparison between dissolution profiles of drug products. , 1997, Journal of biopharmaceutical statistics.

[69]  P. Ding,et al.  Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology. , 2011, International journal of biological macromolecules.

[70]  M. Patel,et al.  Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique , 2004, AAPS PharmSciTech.

[71]  Naveen Ahuja,et al.  Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology , 2006, AAPS PharmSciTech.

[72]  Thomas O'Hara,et al.  A REVIEW OF METHODS USED TO COMPARE DISSOLUTION PROFILE DATA , 1998 .

[73]  Liang-Hsuan Chen.  Designing robust products with multiple quality characteristics , 1997, Comput. Oper. Res..

[74]  C. Fung,et al.  Multi-response optimization in friction properties of PBT composites using Taguchi method and principle component analysis , 2005 .

[75]  Kozo Takayama,et al.  Multi-objective simultaneous optimization based on artificial neural network in a ketoprofen hydrogel formula containing O-ethylmenthol as a percutaneous absorption enhancer , 1997 .

[76]  Ronald L. Rardin,et al.  Optimization in operations research , 1997 .

[77]  Ful-Chiang Wu.  Optimisation of Multiple Quality Characteristics Based on Percentage Reduction of Taguchi’s Quality Loss , 2002 .

[78]  Dennis K. J. Lin,et al.  Multiresponse systems optimization using a goal attainment approach , 2004 .

[79]  D R Lu,et al.  Preparation and evaluation of zidovudine-loaded sustained-release microspheres. 2. Optimization of multiple response variables. , 1996, Journal of pharmaceutical sciences.

[80]  G F Piepel,et al.  Modeling methods for mixture-of-mixtures experiments applied to a tablet formulation problem. , 1999, Pharmaceutical development and technology.

[81]  C. F. Jeff Wu,et al.  Experiments: Planning, Analysis, and Parameter Design Optimization , 2000 .

[82]  S. B. Tiwari,et al.  Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[83]  D Vojnovic,et al.  Experimental design for a pharmaceutical formulation: optimisation and robustness. , 1998, Journal of pharmaceutical and biomedical analysis.

[84]  J N Weinstein,et al.  Neural computing in cancer drug development: predicting mechanism of action. , 1992, Science.

[85]  Mark R Berry,et al.  Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach. , 2007, Journal of pharmaceutical and biomedical analysis.

[86]  H. Goicoechea,et al.  Multiple response optimization applied to the development of a capillary electrophoretic method for pharmaceutical analysis. , 2006, Talanta.

[87]  M Hariharan,et al.  Optimization of sustained-release tablet formulations: a four-component mixture experiment. , 1999, Pharmaceutical development and technology.

[88]  J. W. Moore,et al.  Mathematical comparison of dissolution profiles , 1996 .

[89]  K. Takayama,et al.  Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[90]  M. Macka,et al.  The use of the Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. , 2002, Journal of pharmaceutical and biomedical analysis.

[91]  Sanjeev S. Tambe,et al.  Estimating diffusion coefficients of a micellar system using an artificial neural network , 1995 .

[92]  Frederick S. Hillier,et al.  Introduction of Operations Research , 1967 .

[93]  Rajiv Kumar,et al.  Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspects. , 2005, Critical reviews in therapeutic drug carrier systems.

[94]  Joseph J. Pignatiello,et al.  STRATEGIES FOR ROBUST MULTIRESPONSE QUALITY ENGINEERING , 1993 .

[95]  H Schmidli,et al.  Pitfalls of artificial neural networks (ANN) modelling technique for data sets containing outlier measurements using a study on mixture properties of a direct compressed dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[96]  G. Gauglitz,et al.  Optimization of crushing strength and disintegration time of a high-dose plant extract tablet by neural networks. , 1999, Drug development and industrial pharmacy.

[97]  Sami Nazzal,et al.  D-Optimal Mixture Design: Optimization of Ternary Matrix Blends for Controlled Zero-Order Drug Release From Oral Dosage Forms , 2006, Drug development and industrial pharmacy.

[98]  F. Vrečer,et al.  Characterization of factors affecting the release of low-solubility drug from prolonged release tablets , 2004 .

[99]  Russel J. Mumper,et al.  The Process of New Drug Discovery and Development, 2nd Edition , 1992 .

[100]  Svetlana Ibrić,et al.  The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[101]  M. Khan,et al.  Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. , 2002, International journal of pharmaceutics.

[102]  J. G. Rosas,et al.  Quality by design approach of a pharmaceutical gel manufacturing process, part 1: determination of the design space. , 2011, Journal of pharmaceutical sciences.

[103]  T. Nagai,et al.  Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin. , 1989, Chemical & pharmaceutical bulletin.

[104]  R.-C. Hwang,et al.  A systematic evaluation of the compression and tablet characteristics of various types of microcrystalline cellulose , 2001 .

[105]  B P Smith,et al.  Statistical approach to neural network model building for gentamicin peak predictions. , 1996, Journal of pharmaceutical sciences.

[106]  A. W. Hixson,et al.  Dependence of Reaction Velocity upon surface and Agitation , 1931 .